This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.
Activity Details
503 * | Wed, 8/4/2010, 10:30 AM - 12:20 PM | CC-220 (West) |
Applications of Bayesian Methodology to Clinical Trials in Oncology — Topic Contributed Papers | ||
Biopharmaceutical Section , Committee on Applied Statisticians , ENAR , Section on Bayesian Statistical Science | ||
Organizer(s): Sharon C. Murray, GlaxoSmithKline | ||
Chair(s): Bingming Yi, GlaxoSmithKline | ||
10:35 AM | Bayesian Dose Escalation Using PK as a Covariate — Arun Krishna, Novartis Oncology ; Venkat Sethuraman, Novartis Oncology ; Lu-May Chiang, Novartis Pharmaceuticals Corporation | |
10:55 AM | Bayesian Design for Nonrandomized Phase II Oncology Trials — Yanmei Xu, GlaxoSmithKline ; Bingming Yi, GlaxoSmithKline | |
11:15 AM | A Bayesian Design for a Proof-of-Concept Study Comparing Rituxan in Combination with a New Drug to Rituxan Alone — Sharon C. Murray, GlaxoSmithKline ; John F. Toso, GlaxoSmithKline ; John W. Bauman, GlaxoSmithKline ; | |
11:35 AM | A Bayesian Design with the Time-to-Event Endpoint — Qiong Wang, GlaxoSmithKline | |
11:55 AM | A Hybrid Frequentist-Bayesian Approach to a Pilot Study — Nicole Blackman, GlaxoSmithKline | |
12:15 PM | Floor Discussion |
2010 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.